Amra Hercinovic

538 total citations
7 papers, 84 citations indexed

About

Amra Hercinovic is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Amra Hercinovic has authored 7 papers receiving a total of 84 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Amra Hercinovic's work include Ophthalmology and Eye Disorders (3 papers), Retinopathy of Prematurity Studies (3 papers) and Cerebrospinal fluid and hydrocephalus (2 papers). Amra Hercinovic is often cited by papers focused on Ophthalmology and Eye Disorders (3 papers), Retinopathy of Prematurity Studies (3 papers) and Cerebrospinal fluid and hydrocephalus (2 papers). Amra Hercinovic collaborates with scholars based in United States. Amra Hercinovic's co-authors include Amy K. Hutchinson, David K. Wallace, Michael X. Repka, Scott R. Lambert, Derek T. Sprunger, Christie L. Morse, Oscar A. Cruz, Susan A. Cotter, Danielle L. Chandler and Trevano W. Dean and has published in prestigious journals such as Ophthalmology and Journal of American Association for Pediatric Ophthalmology and Strabismus.

In The Last Decade

Amra Hercinovic

7 papers receiving 83 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amra Hercinovic United States 5 46 39 28 16 15 7 84
Monte A. Del Monte United States 6 42 0.9× 41 1.1× 18 0.6× 25 1.6× 35 2.3× 14 84
Kareem O. Musa Nigeria 6 20 0.4× 47 1.2× 43 1.5× 5 0.3× 4 0.3× 25 85
Roy W. Beck United States 6 62 1.3× 91 2.3× 32 1.1× 14 0.9× 6 0.4× 11 166
Fatimah Chamseddine United States 3 45 1.0× 85 2.2× 61 2.2× 6 0.4× 3 0.2× 8 152
Iuliia A. Rusakova Germany 6 28 0.6× 38 1.0× 30 1.1× 4 0.3× 4 0.3× 12 88
Akira Sugano Japan 6 63 1.4× 69 1.8× 71 2.5× 4 0.3× 15 1.0× 9 96
Yan Ning Neo United Kingdom 7 16 0.3× 103 2.6× 80 2.9× 6 0.4× 3 0.2× 17 149
Duc Quang Nguyen Singapore 6 11 0.2× 136 3.5× 117 4.2× 6 0.4× 10 0.7× 7 163
Yuan Shi Singapore 9 35 0.8× 217 5.6× 171 6.1× 4 0.3× 5 0.3× 11 249
Raphael Kilian Italy 9 29 0.6× 174 4.5× 157 5.6× 6 0.4× 8 0.5× 48 218

Countries citing papers authored by Amra Hercinovic

Since Specialization
Citations

This map shows the geographic impact of Amra Hercinovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amra Hercinovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amra Hercinovic more than expected).

Fields of papers citing papers by Amra Hercinovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amra Hercinovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amra Hercinovic. The network helps show where Amra Hercinovic may publish in the future.

Co-authorship network of co-authors of Amra Hercinovic

This figure shows the co-authorship network connecting the top 25 collaborators of Amra Hercinovic. A scholar is included among the top collaborators of Amra Hercinovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amra Hercinovic. Amra Hercinovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Wallace, David K., Amra Hercinovic, Sharon F. Freedman, et al.. (2023). Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity. Journal of American Association for Pediatric Ophthalmology and Strabismus. 27(1). 10.e1–10.e8. 5 indexed citations
2.
Cruz, Oscar A., Michael X. Repka, Amra Hercinovic, et al.. (2022). Amblyopia Preferred Practice Pattern. Ophthalmology. 130(3). P136–P178. 32 indexed citations
3.
Sprunger, Derek T., Scott R. Lambert, Amra Hercinovic, et al.. (2022). Esotropia and Exotropia Preferred Practice Pattern®. Ophthalmology. 130(3). P179–P221. 8 indexed citations
4.
Hutchinson, Amy K., Christie L. Morse, Amra Hercinovic, et al.. (2022). Pediatric Eye Evaluations Preferred Practice Pattern. Ophthalmology. 130(3). P222–P270. 31 indexed citations
5.
Wallace, David K., Amra Hercinovic, Sharon F. Freedman, et al.. (2022). Two-year ocular and developmental outcomes of a phase 1 dosing study of bevacizumab for retinopathy of prematurity. Journal of American Association for Pediatric Ophthalmology and Strabismus. 26(4). e11–e11. 1 indexed citations
6.
Holmes, Jonathan M., Amra Hercinovic, David A. Leske, et al.. (2021). Health-related quality of life in children with untreated intermittent exotropia and their parents. Journal of American Association for Pediatric Ophthalmology and Strabismus. 25(2). 80.e1–80.e4. 2 indexed citations
7.
Holmes, Jonathan M., Amra Hercinovic, David A. Leske, et al.. (2021). Improvement in health-related quality of life following strabismus surgery for children with intermittent exotropia. Journal of American Association for Pediatric Ophthalmology and Strabismus. 25(2). 82.e1–82.e7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026